11-(2-pyrrolidin-1-yl-ethoxy)-14,19-diox a5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8 ,12)] heptacosa1(25),2(26),3,5,8,10,12(27)j16,21,23-de caene citrate salt

Details for Australian Patent Application No. 2009325147 (hide)

Owner S*BIO Pte Ltd

Inventors Dymock, Brian; Lee, Cheng Hsia Angeline; William, Anthony Deodaunia

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009325147

PCT Pub. Number WO2010/068181

Priority 61/121,668 11.12.08 US

Filing date 9 December 2009

Wipo publication date 17 June 2010

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/068181 Priority application(s): WO2010/068181

6 September 2012 Assignment before Grant

  S*BIO Pte Ltd The application has been assigned to Cell Therapeutics, Inc. Assignments before Grant, Section 113

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009325170-An arrangement related to a gas sensor

2009325140-Systems and methods for optimizing and maintaining visualization of a surgical field during the use of surgical scopes